Mark A Jutila

InstitutionMontana State University
AddressBozeman
Montana
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 4 Covid-19 publications, with a maximum of 2 publications in May 2021
    All Publications
    Bar chart showing 61 publications over 17 distinct years, with a maximum of 7 publications in 2006
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hedges JF, Thompson MA, Snyder DT, Robison A, Taylor MP, Jutila MA. Titers, Prevalence, and Duration of SARS-CoV-2 Antibodies in a Local COVID-19 Outbreak and Following Vaccination. Vaccines (Basel). 2021 Jun 02; 9(6). PMID: 34199357.
      Citations:    
    2. Santiago-Frangos A, Hall LN, Nemudraia A, Nemudryi A, Krishna P, Wiegand T, Wilkinson RA, Snyder DT, Hedges JF, Cicha C, Lee HH, Graham A, Jutila MA, Taylor MP, Wiedenheft B. Intrinsic signal amplification by type III CRISPR-Cas systems provides a sequence-specific SARS-CoV-2 diagnostic. Cell Rep Med. 2021 06 15; 2(6):100319. PMID: 34075364.
      Citations: 5     
    3. Nemudryi A, Nemudraia A, Wiegand T, Nichols J, Snyder DT, Hedges JF, Cicha C, Lee H, Vanderwood KK, Bimczok D, Jutila MA, Wiedenheft B. SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression. Cell Rep. 2021 06 01; 35(9):109197. PMID: 34043946.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    4. Loveday EK, Hain KS, Kochetkova I, Hedges JF, Robison A, Snyder DT, Brumfield SK, Young MJ, Jutila MA, Chang CB, Taylor MP. Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure. Viruses. 2021 03 26; 13(4). PMID: 33810401.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    5. Wiley JA, Richert LE, Swain SD, Harmsen A, Barnard DL, Randall TD, Jutila M, Douglas T, Broomell C, Young M, Harmsen A. Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses. PLoS One. 2009 Sep 23; 4(9):e7142. PMID: 19774076.
      Citations: 58     Fields:    Translation:AnimalsCells